Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro

Clin Exp Immunol. 2007 Aug;149(2):372-7. doi: 10.1111/j.1365-2249.2007.03426.x. Epub 2007 Jun 12.

Abstract

The poor prognosis associated with ovarian carcinoma (OVCA) is linked to the high incidence of local recurrence. There is a pressing need to identify factors that can play a role in OVCA growth and spread. Here, we focused on CD40, a member of the tumour necrosis factor (TNF) receptor superfamily with important functions in immune response. The expression of CD40 has been reported on various types of carcinoma cells, but its biological role is still poorly understood. The aim of the present study was to investigate the expression and function of the CD40 in OVCA cell lines. Detectable CD40 levels ranging from low to very high were found on the cell surface of several OVCA cell lines by flow cytometry analysis. Co-culture with a murine cell line transfected with CD40 ligand (CD40L) inhibited cell growth and up-regulated the secretion of proinflammatory cytokines interleukin (IL)-6, IL-8 and TNF-alpha in high-level CD40-expressing OVCA cell lines. Similarly, an increase of IL-6 and IL-8 release could be obtained by adding a soluble form of CD40L to the OVCA cultures. These results suggest that CD40-CD40L interaction is an important pathway affecting growth regulation and cytokine production in OVCA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / metabolism*
  • CD40 Antigens / metabolism*
  • CD40 Ligand / immunology
  • CD40 Ligand / metabolism
  • Cell Division / immunology
  • Coculture Techniques
  • Cytokines / biosynthesis
  • Female
  • Humans
  • Inflammation Mediators / metabolism
  • Ovarian Neoplasms / immunology*
  • Ovarian Neoplasms / pathology
  • Tumor Cells, Cultured
  • Up-Regulation / immunology

Substances

  • Antigens, Neoplasm
  • CD40 Antigens
  • Cytokines
  • Inflammation Mediators
  • CD40 Ligand